Tylosin Tartrate

Tylosin tartrate is a specialized macrolide antibiotic active pharmaceutical ingredient derived via controlled fermentation and chemical synthesis, engineered specifically for veterinary formulations requiring rapid aqueous dissolution, exceptional purity, and dependable systemic efficacy across livestock production systems.

Molecular Architecture: Formulated primarily from Tylosin A bonded with refined tartaric acid to optimize protonation kinetics and enhance polar solvent affinity.

Mechanism of Action: Binds reversibly to the 50S ribosomal subunits of susceptible microorganisms, halting peptide bond elongation and inhibiting microbial protein synthesis.

Antimicrobial Spectrum: Demonstrates robust efficacy against gram-positive bacteria, select spirochetes, and targeted pathogenic mycoplasma strains.

Pharmacokinetic Behavior: Absorbed rapidly through the gastrointestinal tract following oral administration to achieve therapeutic plasma levels within targeted timeframes.

Aqueous Solubility: Engineered with controlled particle morphology to dissolve entirely in cold water without leaving gelatinous residues or particulate matter.

Thermal Stability: Retains potency stability across standard manufacturing processing corridors, resisting degradation during thermal granulation and blending.

Powder Flowability: Features optimized bulk density and angle of repose values to prevent bridging and segregation during automated powder handling.

Crystalline Consistency: Maintained as a uniform crystalline habit to ensure predictable dissolution release rates in finished dosage forms.

Water-Soluble Powders: Utilized in automated livestock drinking water systems, requiring zero-residue solubility to prevent nipple-drinker occlusion.

Feed Premixes: Blended homogeneously with inert carriers for uniform distribution across large-scale commercial animal feed batches.

Injectable Formulations: Processed to stringent particulate and endotoxin thresholds for sterile liquid suspensions targeting individual therapeutic interventions.

Target Species: Formulated widely for swine respiratory complexes, avian chronic respiratory ailments, and bovine infection management.

Process Impurities: Isolated and quantified via gradient elution HPLC to maintain related substances below stringent regulatory safety thresholds.

Factor Distribution: Guaranteed minimum threshold for the primary Tylosin A component alongside tightly controlled fractions of Tylosin B, C, and D.

Residual Solvents: Verified via gas chromatography to ensure organic volatile impurities comply fully with international pharmacopeial limits.

Degradation Management: Manufactured under strict humidity and temperature corridors to limit hydrolytic cleavage and oxidative breakdown products.

Chromatographic Purity: Assessed using high-performance liquid chromatography equipped with diode array detection for precise peak identification.

Microbiological Limits: Tested for total aerobic count, combined yeast and mold limits, and targeted pathogen absence per pharmacopeial standards.

Batch Uniformity: Multi-point sampling across production runs to confirm absolute homogeneity across every commercial container.

Instrument Calibration: Laboratory testing instruments calibrated daily using certified reference standards traceable to primary international metrology authorities.

Comprehensive Dossiers: Complete technical data packages available to support veterinary product registration submissions across global regulatory jurisdictions.

Analytical Verification: Certificates of Analysis provided for registration, pilot, and commercial validation batches detailing exact test figures.

Safety & Compliance: Safety Data Sheets fully compliant with latest GHS standards, alongside BSE/TSE-free, non-GMO, and allergen declarations.

Methodological Support: Standardized Method of Analysis and Route of Synthesis documents supplied for technical evaluation and auditing.

DMF & Regulatory Coordination: Direct support for active Drug Master Files and Certificate of Suitability submissions aligned with major international regulatory authorities.

Temperature Control: Store between 2 degrees Celsius and 8 degrees Celsius in tightly sealed containers to prevent potency degradation over extended periods.

Humidity Regulation: Keep in low-moisture environments with relative humidity maintained below 60% to avoid caking and moisture absorption.

Light Protection: Shield from direct sunlight and ultraviolet exposure utilizing opaque secondary containment packaging.

Shelf Life Verification: Validated for up to 36 months from the date of manufacture when kept within specified containment parameters.

Primary Containment: Packed inside double-layer food-grade low-density polyethylene bags tied securely with tamper-evident seals.

Secondary Protection: Enclosed within rigid fiber drums or reinforced aluminum-lined containers designed to withstand long-distance transit stress.

Net Weight Standards: Standardized at 25 kg net weight per drum configuration to match standard warehouse handling equipment.

Transit Monitoring: Shipped via temperature-validated freight channels with continuous data logging sensors applied to international cargo loads.

Hot Tags: tylosin tartrate, China tylosin tartrate manufacturers, suppliers, factory, albendazole pharmaceutical grade, avermectin pharmaceutical grade, CAS 70288 86 7, Doxycycline HCI Powder CAS 10592 13 9, erythromycin thiocyanate pharmaceutical standard, levamisole hcl active pharmaceutical ingredient